IVP — Inspire Veterinary Partners Income Statement
0.000.00%
Last trade - 00:00- $8.38m
- $22.10m
- $16.59m
Annual income statement for Inspire Veterinary Partners, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 2.55 | 9.83 | 16.7 | 16.6 |
| Cost of Revenue | |||||
| Gross Profit | — | 0.829 | 2.55 | 3.55 | 3.29 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0 | 3.6 | 13.4 | 24.8 | 27.8 |
| Operating Profit | -0 | -1.05 | -3.52 | -8.12 | -11.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0 | -1.26 | -4.94 | -14.8 | -14.3 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0 | -1.33 | -4.91 | -14.8 | -14.3 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0 | -1.33 | -4.91 | -14.8 | -14.3 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0 | -1.33 | -4.91 | -15.1 | -14.5 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.004 | -298 | -1,099 | -5,275 | -57.5 |
| Dividends per Share |